Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.

Hooper MJ, Ebeling PR, Roberts AP, Graham JJ, Nicholson GC, D'Emden M, Ernst TF, Wenderoth D.

Climacteric. 2005 Sep;8(3):251-62.

PMID:
16390757
2.

Risedronate once a week.

White NJ, Perry CM.

Treat Endocrinol. 2003;2(6):415-20; discussion 421. Review.

PMID:
15981945
3.
4.

[Treatment of osteoporosis by risedronate-- speed, efficacy and safety].

Giljević Z, Vlak T.

Reumatizam. 2006;53(2):66-71. Review. Croatian.

PMID:
17580558
5.

Risedronate: a clinical review.

Crandall C.

Arch Intern Med. 2001 Feb 12;161(3):353-60. Review.

PMID:
11176760
6.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
7.
8.

Risedronate: clinical usage.

Chapurlat RD, Delmas PD.

Int J Clin Pract. 2001 May;55(4):275-8. Review.

PMID:
11406915
9.

Risedronate.

Goa KL, Balfour JA.

Drugs Aging. 1998 Jul;13(1):83-91; discussion 92. Review.

PMID:
9679211
10.

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.

Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group..

Endocr Rev. 2002 Aug;23(4):517-23. Review.

PMID:
12202466
11.

Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis.

Dougherty JA.

Ann Pharmacother. 2002 Mar;36(3):512-6. Review.

PMID:
11895066
12.

In brief: delayed-release risedronate (Atelvia).

[No authors listed]

Med Lett Drugs Ther. 2011 Mar 21;53(1360):24. Review. No abstract available. Erratum in: Med Lett Drugs Ther. 2011 Jun 27;53(1367):52.

PMID:
21412209
Items per page

Supplemental Content

Support Center